These observations were supported by the study of animal models based on KRAS-driven tumorigenesis, associated with loss of TGF-β signaling, reproducing the phenotype observed in primary human tumor samples and supporting also the role for STAT3 as an inducer of the tissutal fibrotic response [39]. The gene discussed is KRAS; the disease is neoplasm.